Kevin Kim

6.5k total citations · 3 hit papers
100 papers, 4.3k citations indexed

About

Kevin Kim is a scholar working on Molecular Biology, Oncology and Electrical and Electronic Engineering. According to data from OpenAlex, Kevin Kim has authored 100 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 38 papers in Oncology and 15 papers in Electrical and Electronic Engineering. Recurrent topics in Kevin Kim's work include Melanoma and MAPK Pathways (22 papers), CAR-T cell therapy research (13 papers) and Radio Frequency Integrated Circuit Design (12 papers). Kevin Kim is often cited by papers focused on Melanoma and MAPK Pathways (22 papers), CAR-T cell therapy research (13 papers) and Radio Frequency Integrated Circuit Design (12 papers). Kevin Kim collaborates with scholars based in United States, Germany and Australia. Kevin Kim's co-authors include Richard W. Carthew, Kenji Nakahara, Young Sik Lee, Erik J. Sontheimer, Zhengying He, John Pham, Kheng B. Lim, Samuel I. Miller, Lin Guo and Murray Hackett and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Kevin Kim

95 papers receiving 4.2k citations

Hit Papers

Distinct Roles for Drosophila Dicer-1 and Dicer-2 in the ... 1998 2026 2007 2016 2004 2006 1998 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Kim United States 24 2.6k 803 703 586 574 100 4.3k
Alejandro Chavez United States 27 4.3k 1.7× 295 0.4× 404 0.6× 423 0.7× 283 0.5× 48 5.2k
Jason Wright United States 12 7.9k 3.1× 936 1.2× 914 1.3× 462 0.8× 843 1.5× 16 9.8k
Emmanuel Lemichez France 39 3.5k 1.4× 235 0.3× 1.0k 1.4× 633 1.1× 400 0.7× 121 6.0k
Todd Wylie United States 29 1.7k 0.7× 543 0.7× 977 1.4× 491 0.8× 880 1.5× 54 4.2k
Yang Shen China 35 2.8k 1.1× 834 1.0× 483 0.7× 508 0.9× 132 0.2× 115 5.0k
Margit Mahlapuu Sweden 34 3.8k 1.5× 311 0.4× 548 0.8× 159 0.3× 247 0.4× 72 5.8k
Matthew H. Larson United States 14 8.2k 3.2× 445 0.6× 216 0.3× 658 1.1× 376 0.7× 19 8.9k
Georges Lutfalla France 39 1.5k 0.6× 321 0.4× 3.1k 4.4× 392 0.7× 1.3k 2.3× 87 5.5k
Evan H. Whitehead United States 10 5.5k 2.1× 362 0.5× 176 0.3× 429 0.7× 315 0.5× 20 6.2k
Andreas S. Richter Germany 16 5.0k 1.9× 619 0.8× 496 0.7× 1.0k 1.7× 268 0.5× 21 6.1k

Countries citing papers authored by Kevin Kim

Since Specialization
Citations

This map shows the geographic impact of Kevin Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Kim more than expected).

Fields of papers citing papers by Kevin Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Kim. The network helps show where Kevin Kim may publish in the future.

Co-authorship network of co-authors of Kevin Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Kim. A scholar is included among the top collaborators of Kevin Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Kim. Kevin Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Saeed, Muhammad A., Kevin Kim, Kavita Rawat, et al.. (2024). High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance. Cancer Immunology Research. 12(5). 559–574. 4 indexed citations
3.
Algazi, Alain P., James Moon, Christopher D. Lao, et al.. (2024). A phase 1 study of triple‐targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF‐mutated cancers. Cancer. 130(10). 1784–1796. 6 indexed citations
4.
Kim, Kevin, et al.. (2023). Design and Synthesis of RISC-V Bit Manipulation Extensions. 1559–1563. 1 indexed citations
6.
Iyer, Renuka, Nainesh Parikh, Richard D. Kim, et al.. (2023). A phase II study of atezolizumab (ATEZO) and bevacizumab (BEV) in combination with Y90 TARE in patients (pts) with hepatocellular carcinoma (HCC): Y90+/- BEAT.. Journal of Clinical Oncology. 41(4_suppl). TPS629–TPS629. 3 indexed citations
7.
Lee, Michelle V., Kevin Kim, Katerina Konstantinoff, et al.. (2021). Recent Trends in Screening Breast MRI. Journal of Breast Imaging. 4(1). 39–47. 5 indexed citations
8.
He, Aiwu Ruth, Kabir Mody, Kevin Kim, et al.. (2021). A phase II study of atezolizumab (ATEZO) and bevacizumab (Bev) in combination with Y90 TARE in patients (Pts) with hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 39(3_suppl). TPS358–TPS358. 4 indexed citations
11.
Vanyukov, Michael M., Kevin Kim, Daniel E. Irons, et al.. (2014). Genetic Relationship Between the Addiction Diagnosis in Adults and Their Childhood Measure of Addiction Liability. Behavior Genetics. 45(1). 1–11. 13 indexed citations
12.
Chen, Yingxi, Kevork Hagopian, Doug Bibus, et al.. (2014). The Influence of Dietary Lipid Composition on Skeletal Muscle Mitochondria From Mice Following Eight Months of Calorie Restriction. Physiological Research. 63(1). 57–71. 13 indexed citations
13.
Marques, João T., et al.. (2009). Loqs and R2D2 act sequentially in the siRNA pathway in Drosophila. Nature Structural & Molecular Biology. 17(1). 24–30. 124 indexed citations
14.
Coskun, Volkan, Hao Wu, Bruno Blanchi, et al.. (2008). CD133 + neural stem cells in the ependyma of mammalian postnatal forebrain. Proceedings of the National Academy of Sciences. 105(3). 1026–1031. 258 indexed citations
15.
Bedikian, Agop Y., Marcella M. Johnson, Carla L. Warneke, et al.. (2008). Prognostic Factors That Determine the Long-Term Survival of Patients with Unresectable Metastatic Melanoma. Cancer Investigation. 26(6). 624–633. 57 indexed citations
16.
Quintás‐Cardama, Alfonso, Alexander J. Lazar, Scott E. Woodman, et al.. (2008). Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib. Nature Clinical Practice Oncology. 5(12). 737–740. 89 indexed citations
17.
Wang, Xiaohong, Roghiyh Aliyari, Wan-Xiang Li, et al.. (2006). RNA Interference Directs Innate Immunity Against Viruses in Adult Drosophila. Science. 312(5772). 452–454. 580 indexed citations breakdown →
18.
Kim, Kevin, Young Sik Lee, & Richard W. Carthew. (2006). Conversion of pre-RISC to holo-RISC by Ago2 during assembly of RNAi complexes. RNA. 13(1). 22–29. 77 indexed citations
19.
Nakahara, Kenji, Kevin Kim, Christin Sciulli, et al.. (2005). Targets of microRNA regulation in the Drosophila oocyte proteome. Proceedings of the National Academy of Sciences. 102(34). 12023–12028. 68 indexed citations
20.
Lee, Young Sik, Kenji Nakahara, John Pham, et al.. (2004). Distinct Roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA Silencing Pathways. Cell. 117(1). 69–81. 1002 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026